Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery

NCT ID: NCT01509950

Last Updated: 2019-03-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-05-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Currently different materials are used to close the skin after a cesarean delivery, including absorbable suture, non-absorbable suture and staples. It is not known what is the best choice of material to close the skin after a cesarean section, but commonly staples or dissolvable suture is used. Recently plastic surgeons have found that non-dissolvable suture may have a better cosmetic outcome than staples. The investigators hope to learn if there is a difference in pain both at suture/staple removal and 6 weeks postoperatively between Prolene suture, Absorbable suture (monocryl or vicryl) or staples. The investigators also plan to look for differences in wound complications and patient satisfaction, as well as operating and removal times. This knowledge will be important in helping practitioners choose the closure technique at cesarean delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who meet inclusion criteria will be approached upon admission to Labor and Delivery. A study staff member will describe the study and offer participation. If a patient agrees to participate, she will sign research protocol and HIPAA consent forms and receive a copy of these forms. The patient's chart will be flagged, indicating that she is a study participant. The patient's prenatal care and labor and delivery will be managed by her physician per standard of care at the physician's discretion, including routine surgical preparation and procedures.

When a participating patient is scheduled for a cesarean section, she will be randomized to Arm 1 (Staples) or Arm 2 (Prolene) or Arm 3 (Monocryl or Vicryl absorbable suture). She will be treated as per standard of care and her cesarean section performed per physician discretion. After the closure of the fascial layer, the surgeons will follow the same protocol for each study participant, including wound irrigation with warm sterile saline and reapproximation of the subcutaneous layer if greater than 2.0 cm in depth (per standard of care). The patient in Arm 1 will have skin closure with staples. The patient in Arm 2 will have skin closure with 2-0 Prolene in a subcuticular fashion. The patient in Arm 3 will have skin closure with monocryl or vicryl in the standard fashion. Patients in Arms 1 and 2 will have their closure material removed at the physician's discretion per the standard of care at post-operative day 3 or 4.

Pain level will be assessed on the first and third or fourth day after surgery and again at six weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Cesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Staples

Use of staples for skin closure at cesarean section

Group Type ACTIVE_COMPARATOR

Staples

Intervention Type PROCEDURE

Staples for closure of cesarean section skin incision

Prolene non-absorbable sutures

Use of Prolene non-absorbable sutures for skin closure at cesarean section

Group Type ACTIVE_COMPARATOR

Prolene non-absorbable sutures

Intervention Type PROCEDURE

Prolene non-absorbable sutures for closure of cesarean skin incision

Absorbable sutures

Use of absorbable sutures for skin closure at cesarean section; monocryl or vicryl.

Group Type ACTIVE_COMPARATOR

Absorbable Sutures

Intervention Type PROCEDURE

Absorbable sutures for closure of cesarean skin incision

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Staples

Staples for closure of cesarean section skin incision

Intervention Type PROCEDURE

Prolene non-absorbable sutures

Prolene non-absorbable sutures for closure of cesarean skin incision

Intervention Type PROCEDURE

Absorbable Sutures

Absorbable sutures for closure of cesarean skin incision

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Reflex one skin stapler 35 wide. Manufactured by Conmed Prolene 2-0 18 inch on FS needle. Manufactured by Ethicon Monocryl or Vicryl. Manufactured by Ethicon

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women undergoing primary or repeat cesarean section
* Maternal age greater than or equal to 18 years of age
* Gestational age greater than or equal to 34 weeks
* Elective and non-elective cesarean section

Exclusion Criteria

* Type 1 or Type 2 diabetes
* BMI greater than 35
* Pre-operative diagnosis of chorioamnionitis
* History of drug or alcohol abuse
* Contraindication to NSAIDs
* Chronic pain diagnosis
* Narcotic use prior to pregnancy
* Maternal age less than 18 years of age
* General anesthesia
* Chorioamnionitis, clinical suspicion of chorioamnionitis, or risk factors for chorioamnionitis (membrane rupture greater than 18 hours, GBS positive status)
* Vertical skin incision
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Natali Aziz

Clinical Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natali Aziz, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lucile Packard Childrens Hospital

Palo Alto, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22389

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Skin Glue Cesarean Study
NCT05903547 ACTIVE_NOT_RECRUITING NA